Mangalam Drugs and Organics Ltd

NSE
MANGALAM •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Mangalam Drugs and Organics Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
28.68% Gain from 52W Low
23.7
TTM PE Ratio
Negative PE TTM
-11.3
Price to Book Ratio
Low in industry
1.3
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI is mid-range
58
MFI
MFI is mid-range
68.7

Mangalam Drugs and Organics Ltd Key Financials

*All values are in ₹ Cr.

Mangalam Drugs and Organics Ltd shareholding Pattern

Promoter
50.3%
Foreign Institutions
0.1%
Public
49.6%

Mangalam Drugs and Organics Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
4
5Day EMA
122.30
10Day EMA
120.90
12Day EMA
120.20
20Day EMA
117.10
26Day EMA
115.30
50Day EMA
110.50
100Day EMA
107.10
200Day EMA
108.00
Delivery & Volume
Resistance & Support
123.12
Pivot
Resistance
First Resistance
126.13
Second Resistance
131.57
Third Resistance
134.58
Support
First Support
117.68
Second support
114.67
Third Support
109.23
Relative Strength Index
57.97
Money Flow Index
68.70
MACD
4.88
MACD Signal
4.62
Average True Range
7.16
Average Directional Index
31.71
Rate of Change (21)
16.67
Rate of Change (125)
17.41

Mangalam Drugs and Organics Ltd Company background

Founded in: 1972
Managing director: Govardhan M Dhoot
Mangalam Drugs and Organics Ltd is an Indiabased company. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an inhouse Research and Development (RD) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.Mangalam Drugs and Organics Ltd was incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In July 1, 1997, the company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. In September 22, 1997, the company was converted into a deemed public company and word private was deleted from the companys name. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In August 10, 2001, the company was converted into a full fledged public limited company.In the year 20032004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 200405, the capacity is being further enhanced to 960 MTPA. During the year 200506, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum.During the year 200708, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline Allied Products from 250 tons to 350 tons.During the year 200910, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHOGeneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.
Read More

Mangalam Drugs and Organics Ltd FAQs

Mangalam Drugs and Organics Ltd shares are currently priced at 120.7 on NSE and 120.6 on BSE as of 2/27/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Mangalam Drugs and Organics Ltd [MANGALAM] share was 15.77. The Mangalam Drugs and Organics Ltd [MANGALAM] share hit a 1-year low of Rs. 93.8 and a 1-year high of Rs. 132.45.

The market cap of Mangalam Drugs and Organics Ltd is Rs. 191.05 Cr. as of 2/27/2024 12:00:00 AM.

The PE ratios of Mangalam Drugs and Organics Ltd is 0 as of 2/27/2024 12:00:00 AM.

The PB ratios of Mangalam Drugs and Organics Ltd is 1.37 as of 2/27/2024 12:00:00 AM

You can easily buy Mangalam Drugs and Organics Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage